Don’t Miss Our Inaugural Event for Biosimulation Users
Join us for an in-person event where you can learn from drug development experts, network…
Jim Gallagher2024 年 3 月 26 日
Hallmarks of neurodegenerative disease: A systems pharmacology perspective
Authors: Peter Bloomingdale, Tatiana Karelina, Vidya Ramakrishnan, Suruchi Bakshi, Florence Véronneau-Veilleux, Matthew Moye, Kazutaka Sekiguchi,…
Jim Gallagher2024 年 3 月 22 日
How Drug Discovery Tools Aid Pharma Decision-Making
Learn how drug discovery tools can help pharmaceutical industry professionals make more informed decisions based…
Jim Gallagher2024 年 3 月 22 日
Why Medical/Regulatory Writing Services Use Style Guides & Lexicons
Learn how style guides and lexicons help medical writers produce clear, consistent, and accurate content…
Jim Gallagher2024 年 3 月 18 日
Certara Reports Fourth Quarter 2023 Financial Results
Provides Full Year 2024 Financial Guidance PRINCETON, N.J.— 2024 年 2 月 29 日-- Certara, Inc. （纳斯达克股票代码：CERT), a…
Jim Gallagher2024 年 2 月 29 日
Guide to development of compound files for PBPK modeling in the Simcyp population-based simulator
The Simcyp Simulator is a software platform for population physiologically-based pharmacokinetic (PBPK) modeling and simulation.…
Jim Gallagher2024 年 2 月 23 日
RAPS: How Will Generative AI Take Your Regulatory and Medical Writing Program to the Next Level?
Drug developers face increasing pressures to accelerate the drug development process, including reducing submission timelines.…
Jim Gallagher2024 年 2 月 22 日
How to Navigate the FDA Landscape for an Orphan Drug
罕见病是公共卫生领域的优先事项。FDA has launched several programs and a final…
Jim Gallagher2024 年 2 月 21 日
